Home > Healthcare > Medical Devices > Implantable Devices > Coronary Artery Bypass Graft Market

Coronary Artery Bypass Graft Market Trends

Report ID: GMI8564
Published Date: Nov 2024
Report Format: PDF

Download Free Sample

Coronary Artery Bypass Graft Market Trends

Minimally invasive CABG techniques, including robotic-assisted surgeries, are gaining popularity due to shorter recovery times, reduced hospital stays, and lower risk of complications. Robotic and endoscopic-assisted CABG procedures are becoming more common among patients and surgeons for their precision and effectiveness.
According to UCSF Health, minimally invasive CABG procedures have shown a significant reduction in hospital stay duration and shorter recovery time compared to traditional open-heart surgery. This trend towards less invasive techniques is likely to continue as technology advances and surgical expertise grows.
Additionally, hybrid revascularization procedures, combining CABG with percutaneous coronary interventions (PCI), are emerging as an effective approach for treating complex coronary artery disease. This method allows for improved treatment of multi-vessel disease by integrating the benefits of both surgical and non-surgical techniques, resulting in better patient outcomes.
Furthermore, off-pump coronary artery bypass (OPCAB), which avoids the use of a heart-lung machine, is increasingly preferred as it reduces complications associated with on-pump procedures, such as bleeding and cognitive dysfunction. OPCAB is particularly suitable for high-risk patients and offers benefits including reduced post-operative recovery time.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global market for coronary artery bypass graft was reached USD 11.8 billion in 2023 and is estimated to grow at a 7.1% CAGR from 2024 to 2032, driven by the increasing prevalence of cardiovascular diseases.

The traditional (on-pump) CABG segment dominated the market with a 55.1% revenue share in 2023, due to its established efficacy and widespread adoption in surgical practices.

The grafts segment was valued at over USD 3.1 billion in 2023, as these are essential components in CABG procedures.

The U.S. coronary artery bypass graft market surpassed USD 3.5 billion in 2023 and is expected to grow at a 6.7% CAGR through 2032, led by favorable reimbursement policies and advanced healthcare infrastructure.

Key players in the industry include Abbott Laboratories, AngioDynamics, AtriCure, B. Braun Melsungen AG, Boston Scientific, Cardinal Health, CryoLife, Edwards Lifesciences, Johnson & Johnson, LivaNova, Medline Industries, Medtronic, Nipro Corporation, Stryker Corporation, and Terumo Corporation.